Drugs / SN514-066b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06628037 | May 2025 → May 2026 overdue | — | SERDA bv | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SN514-066b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06628037 ↗ |
| Modality | Protein / enzyme biologic | “the enzyme SN514” NCT06628037 ↗ |
| Route | Topical | “applied topically” NCT06628037 ↗ |